In pediatric patients with KMT2A/MLL-R+ AML, the gene expression levels for FLT3, BTK, SYK, JAK2/JAK3, as well as several SRC family PTK were differentially amplified [Figure 4; Supplementary Table 9]. The gene discussed is JAK2; the disease is acute myeloid leukemia.